Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]fluoride PET-CT imaging of bone formation in spondyloarthritis during secukinumab treatment
NL-OMON52517Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Oct 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of secukinumab, sponsored by Vrije University Medical Center. Started Oct 2018; status: recruiting.
02
Drugs
secukinumab
Beyond the preview
Go deeper on NL-OMON52517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52517.